FDA grants EUA for Sputnik V vaccine

The Philippine FDA has granted an emergency use authorization (EUA) for Russia's Sputnik V vaccine, making it the fourth vaccine to receive regulatory approval in the country.

FDA Director General Eric Domingo stated that the vaccine's known and potential benefits outweigh its risks, but it can only be used on individuals aged 18 years and older.

Vaccine czar Carlito Galvez Jr. announced that the Philippines will purchase three million doses of Sputnik V, with procurement expected in April.

The Russian vaccine demonstrated 91.6% efficacy in a late-stage trial.

The FDA had previously canceled an inspection trip to Russia after the manufacturer submitted additional documents for its application.